Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 15.96MWorking Capital
VS
Market
Sector
Industry
History
$ 2.04Close
$ 0.25 - $ 3.64 52-Week Range
Ticker Information
Ticker
RLMDCompany Name
RELMADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRELMADA THERAPEUTICS INC - Working Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RLMD - Working Capital Historical data
| Date | Current Assets | Current Liabilities | Working Capital |
|---|---|---|---|
| 6/30/2025 | $ 21.09M | $ 5.13M | $ 15.96M |
| 3/31/2025 | $ 27.66M | $ 5.23M | $ 22.43M |
| 12/31/2024 | $ 45.8M | $ 10.29M | $ 35.5M |
| 9/30/2024 | $ 55.7M | $ 8.09M | $ 47.62M |
| 6/30/2024 | $ 70.97M | $ 9.54M | $ 61.44M |
| 3/31/2024 | $ 84.37M | $ 12.36M | $ 72M |
| 12/31/2023 | $ 97.51M | $ 12.19M | $ 85.31M |
| 9/30/2023 | $ 109.1M | $ 8.42M | $ 100.68M |
| 6/30/2023 | $ 122M | $ 10.7M | $ 111.3M |
| 3/31/2023 | $ 135.53M | $ 10.1M | $ 125.43M |
Key Performance Insights, Last 5 Years
- RELMADA THERAPEUTICS INC's latest trailing twelve months (TTM) Working Capital stands at $ 122.08M.
- Over the past 5 years, RELMADA THERAPEUTICS INC's average Working Capital has been $ 104.39M.
- The median Working Capital for RELMADA THERAPEUTICS INC during this period was $ 98.73M
- RELMADA THERAPEUTICS INC reached its highest Working Capital over the past 5 years at $ 210.37M.
- The lowest Working Capital recorded by RELMADA THERAPEUTICS INC in the same timeframe $ 15.96M
Similar metrics to Working Capital:
- Current Ratio - [Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
- Non-Current Liabilities - [Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
Definition of Working Capital
[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].AssetsC - LiabilitesC
(=) Working Capital Working Capital for RELMADA THERAPEUTICS INC is calculated as follows: AssetsC [ $ 125.47M ] - LiabilitesC [ $ 3.39M ]
(=) Working Capital [ $ 122.08M ] RLMD - Working Capital, Last 5 years
$ 15.96M
Minimum
Jun 30, 2025
$ 210.37M
Maximum
Mar 31, 2022
$ 104.39M
Average
$ 98.73M
Median
Working Capital Benchmark AnalysisMarket
The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.44M with a standard deviation of $ 173.86M.
The following table provides additional summary stats:
Working Capital in the Market:
| filtered constituents | 2.78K |
|---|---|
| min | $ -465.2M |
| max | $ 607.04M |
| average | $ 96.44M |
| median | $ 32.21M |
| std | $ 173.86M |